Viral Particles Drive Rapid Differentiation of Memory B Cells into Secondary Plasma Cells Producing Increased Levels of Antibodies

Viral Particles Drive Rapid Differentiation of Memory B Cells into Secondary Plasma Cells Producing Increased Levels of Antibodies

Mostrar outras versões (1)

Detalhes bibliográficos
Principais autores:	Zabel, F, Mohanan, D, Bessa, J, Link, A, Fettelschoss, A, Saudan, P, Kuendig, T, Bachmann, M
Formato:	Conference item
Publicado em:	2014

Registros relacionados

Viral particles drive rapid differentiation of memory B cells into secondary plasma cells producing increased levels of antibodies.
por: Zabel, F, et al.
Publicado em: (2014)

The kinetics of a memory B cell response to virus like particles in mice
por: Zabel, F, et al.
Publicado em: (2012)

Low-affinity B cells transport viral particles from the lung to the spleen to initiate antibody responses.
por: Bessa, J, et al.
Publicado em: (2012)

B cell TLRs and the antibody response to virus particles
por: DeFranco, A, et al.
Publicado em: (2011)

Regulation of memory antibody levels: the role of persisting antigen versus plasma cell life span.
por: Gatto, D, et al.
Publicado em: (2007)

Rapid response of marginal zone B cells to viral particles.
por: Gatto, D, et al.
Publicado em: (2004)

Bacterially produced recombinant influenza vaccines based on virus-like particles
por: Jegerlehner, A, et al.
Publicado em: (2013)

Bacterially produced recombinant influenza vaccines based on virus-like particles.
por: Andrea Jegerlehner, et al.
Publicado em: (2013-01-01)

Carrier induced epitopic suppression of antibody responses induced by virus-like particles is a dynamic phenomenon caused by carrier-specific antibodies.
por: Jegerlehner, A, et al.
Publicado em: (2010)

Cutting edge: limited specialization of dendritic cell subsets for MHC class II-associated presentation of viral particles.
por: Keller, SA, et al.
Publicado em: (2010)

Cytokine production by peripheral blood cells following therapy with a combined vaccine of allergen and QbG10
por: Manolova, V, et al.
Publicado em: (2008)

Vaccination against Alzheimer disease: an update on future strategies.
por: Fettelschoss, A, et al.
Publicado em: (2014)

Alveolar macrophages and lung dendritic cells sense RNA and drive mucosal IgA responses.
por: Bessa, J, et al.
Publicado em: (2009)

Adjusted particle size eliminates the need of linkage of antigen and adjuvants for appropriated T cell responses in virus-like particle-based vaccines.
por: Gomes, A, et al.
Publicado em: (2017)

Follicular and marginal zone B cells fail to cross-present MHC class I-restricted epitopes derived from viral particles.
por: Keller, SA, et al.
Publicado em: (2009)

Virus-Specific Secondary Plasma Cells Produce Elevated Levels of High-Avidity Antibodies but Are Functionally Short Lived
por: Caroline C. Krueger, et al.
Publicado em: (2019-08-01)

Isolation of human monoclonal antibodies by mammalian cell display.
por: Beerli, R, et al.
Publicado em: (2008)

Secondary influenza challenge triggers resident memory B cell migration and rapid relocation to boost antibody secretion at infected sites
por: MacLean, AJ, et al.
Publicado em: (2022)

Rapid functional cloning of cell adhesion molecules
por: Christiane Ruedl, et al.
Publicado em: (2004-12-01)

Broadly neutralizing anti-HIV-1 antibodies tether viral particles at the surface of infected cells
por: Jérémy Dufloo, et al.
Publicado em: (2022-02-01)

Secondary Particles Produced by Hadron Therapy
por: Abdolkazem Ansarinejad, et al.
Publicado em: (2015-07-01)

Protection against immunopathological consequences of a viral infection by activated but not resting cytotoxic T cells: T cell memory without "memory T cells"?
por: Bachmann, M, et al.
Publicado em: (1997)

Heterogeneous antibody repertoire of marginal zone B cells specific for virus-like particles.
por: Gatto, D, et al.
Publicado em: (2007)

T cell responses are governed by avidity and costimulatory thresholds
por: Bachmann, M, et al.
Publicado em: (1996)

Virus-like particles as carriers for T-cell epitopes: limited inhibition of T-cell priming by carrier-specific antibodies.
por: Ruedl, C, et al.
Publicado em: (2005)

Nanoparticles target distinct dendritic cell populations according to their size
por: Manolova, V, et al.
Publicado em: (2007)

Targeted killing of virally infected cells by radiolabeled antibodies to viral proteins.
por: Ekaterina Dadachova, et al.
Publicado em: (2006-11-01)

APOBEC3B expression in 293T viral producer cells drives mutations in chimeric antigen receptors and reduces CAR T cell efficacy
por: Jack Swanson, et al.
Publicado em: (2024-12-01)

Alveolar macrophages and lung dendritic cells sense RNA and drive mucosal IgA responses
por: Bessa, J, et al.
Publicado em: (2009)

Defective Viral Particles Produced in Mast Cells Can Effectively Fight Against Lethal Influenza A Virus
por: Caiyun Huo, et al.
Publicado em: (2020-11-01)

IgG-mediated down-regulation of IgE bound to mast cells: A potential novel mechanism of allergen-specific desensitization
por: Uermösi, C, et al.
Publicado em: (2014)

IgG-mediated down-regulation of IgE bound to mast cells: a potential novel mechanism of allergen-specific desensitization.
por: Uermösi, C, et al.
Publicado em: (2014)

Highly sensitive and quantitative HiBiT-tagged Nipah virus-like particles: A platform for rapid antibody neutralization studies
por: Arathi Rajan, et al.
Publicado em: (2024-06-01)

Reliability of pseudotyped influenza viral particles in neutralizing antibody detection.
por: Jinghui Yang, et al.
Publicado em: (2014-01-01)

Free recirculation of memory B cells versus antigen-dependent differentiation to antibody-forming cells.
por: Bachmann, M, et al.
Publicado em: (1994)

Distinct kinetics of cytokine production and cytolysis in effector and memory T cells after viral infection.
por: Bachmann, M, et al.
Publicado em: (1999)

Limited in vivo reactivity of polyclonal effector cytotoxic T cells towards altered peptide ligands.
por: Bättig, P, et al.
Publicado em: (2005)

Epithelial stem cells are formed by small-particles released from particle-producing cells.
por: Wuyi Kong, et al.
Publicado em: (2017-01-01)

A viral fusogen hijacks the actin cytoskeleton to drive cell-cell fusion
por: Ka Man Carmen Chan, et al.
Publicado em: (2020-05-01)

NNKTT120, an anti-iNKT cell monoclonal antibody, produces rapid and sustained iNKT cell depletion in adults with sickle cell disease.
por: Joshua J Field, et al.
Publicado em: (2017-01-01)